Class II · Moderate riskOngoing Initiated Jun 30, 2025 (14 months ago)
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
What was recalled
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
Recalling firm
Cipla USA, Inc.
NDC code
69097-319-86
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0541-2025
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles…
Sun Pharmaceutical Industries INCNDC 47335-633-49D-0607-2026